The sequencing of the human genome and the identification of a vast array of DNA polymorphisms has afforded cognitive scientists with the opportunity to interrogate the genetic basis of cognition with renewed vigor. The extant literature on the molecular genetics of sustained and spatial attention is reviewed herein. Advances in our understanding of the neural substrates of sustained and spatial attention arising from the cognitive neurosciences can help guide putative linkages in cognitive genetics. In line with catecholamine models of sustained attention, associations have been reported between sustained attention and allelic variation in the dopamine beta hydroxylase gene (DBH), the dopamine D2 and D4 receptor genes (DRD2; DRD4) and the dopamine transporter gene (DAT1). Much evidence implicates the cholinergic system in spatial attention. Accordingly, individual differences in spatial attention have been associated with variation in an alpha-4 cholinergic receptor gene (CHRNA4). APOE-ε4 allele dosage has been shown to influence the speed of attentional reorienting in independent samples of nonaffected individuals. Preliminary evidence in both healthy children and children with attention deficit hyperactivity disorder (ADHD) suggests and association with variants of the DAT1 gene and the control of spatial attention across the hemifields. With the recent development of high-throughput genotyping techniques, such as microarrays, the time seems ripe for a genomewide association study that can identify quantitative trait loci (QTLs) for sustained and spatial attention. The identification of QTLs for attention will provide a range of novel candidate genes for disorders of attention, such as ADHD and schizophrenia, and will drive cognitive neuroscientists to understand how DNA variation influences the neural substrates of attention.
Introduction
Science has long sought to determine whether individual differences in cognitive capacity can be ascribed to differences in underlying genetics. In the past, behavior genetics addressed this question by parsing the genetic and environmental contributions to cognition using the classic twin design. These studies have clearly achieved much by showing that complex cognition, as assessed, for example, by general intelligence measures, such as "g," is strongly influenced by genes. 1 More recently this endeavor has gained new impetus with the sequencing of the human genome, so that scientists can now ask how variation within a specific gene influences individual differences in a specific cognitive process. These advances in molecular genetics have provided those working in cognitive neuroscience with the opportunity to interrogate old questions in entirely new ways and allow the testing of cognitive models at a new level of analysis.
The application of molecular genetics to studies of cognition-cognitive genetics-follows strongly in the tradition of cognitive neuropsychology. 2 In the latter, the effects of localized cerebral lesions on specific cognitive functions have thrown considerable light on the cognitive architecture of the normally functioning human brain. 3 For example, the syndrome of unilateral spatial neglect, in which patients display deficits in detecting and acting upon contralesional stimuli is most frequent and severe following lesions centered on the posterior parietal lobe of the right cerebral hemisphere. 4 The central role played by this region in human spatial attention has been confirmed by numerous neuroimaging studies with healthy participants who have shown activity in the right temporoparietal junction, particularly when observers must shift their attention from an invalidly cued location to detect a target at a contralateral location. 5, 6 In the case of cognitive genetics, specific allelic variants of candidate genes (see TABLE 1) take the place of specific cerebral lesions, and so a linkage is made between A gene located on a chromosomal region that is thought to be involved in a trait (e.g., cognitive process) or a disorder (e.g., ADHD). Candidate genes are normally chosen based on prior physiological, genetic, or biochemical characterisation that leads one to suspect that this gene is involved in the trait. Haplotype A set of closely linked alleles inherited as a unit. These linked SNPs may be useful in defining a haplotype block that may harbor a causative variant for a trait. Intron A nucleotide sequence in a gene that does not code for the gene product. Introns can be compared to exons, which are the protein-coding portion of a gene. Linkage disequilibrium (LD) LD occurs when alleles at different loci occur together within an individual at a greater than chance frequency. Single nucleotide polymorphism (SNP) Different versions of a gene, due to differences in nucleotides on DNA, are called polymorphisms. The most common form of genetic variation, the SNP, reflects a change in a single base in the DNA that differs from the usual base at that position.
Adapted from Bellgrove et al. 2 cognitive functions on the one hand, and molecular genetics on the other. Such linkages are essential to test contemporary models of cognition, such as those advanced for attention, 6,7 which include variables across very different domains of enquiry-cognitive, anatomical, neurochemical, and now genetic.
In this chapter we review studies that have sought an association between allelic variation in a candidate gene and individual differences in attention. Aspects of this work were previously presented in Bellgrove et al. 2 From the outset it is worth reminding ourselves that the ability to isolate a genetic contribution to any observable behavior is reliant upon the precision and reliability with which one can measure that behavior: "A poorly-defined phenotype is unlikely to facilitate the identification of the underlying genotype" (Baddeley, 1996, p. 186). If, however, the cognitive process itself is well understood in cognitive-neuroanatomical terms, then progress may be made in determining how the gene contributes to variation in the development of brain mechanisms modulating that cognitive process. A sound cognitive-neuroanatomical model can thus assist in identifying appropriate candidate genes and can reduce the potential for Type I errors which is attendant in all genetic-association studies.
A Cognitive-Neuroanatomical Model of Sustained Attention
Our own neuropsychological and rehabilitation research on the attentional sequelae of traumatic brain injury (TBI), stroke, and, more recently, attention deficit hyperactivity disorder (ADHD), has been heavily influenced by neuroanatomical models of attention that propose distinct attentional systems for the control of spatial attention and nonspatial alertness. [7] [8] [9] We have defined nonspatial alertness, or sustained attention, as the internal control of cognitive readiness in the absence of exogenous support. In contrast, spatial selectivity refers to the processes that filter sensory stimuli based upon their spatial locations; representations of inputs at attended locations are selected for further processing, whereas those at unattended locations are suppressed.
Several sources of information converge to suggest a predominant role of the right prefrontal cortex in sustained attention. First, it is well established that right frontal lesions lead to an increase in reaction time when an imperative stimulus is not preceded by a warning signal. 10 Such frontal patients nevertheless benefit from a warning signal, indicating that it is the tonic rather than the phasic aspects of alertness that are impaired with right-frontal lesions. 10, 11 Wilkins and colleagues 9 demonstrated that patients with right-frontallobe lesions were specifically impaired when required to perform a simple tone-counting task with a particularly slow event rate. These authors concluded that a monotonous task impaired the right-frontal patient's ability to sustain attention. A right-frontal focus for sustained attention is also consistent with the cortical distribution of noradrenergic neurons arising predominantly from the locus coeruleus. 12 Accordingly, drugs that suppress noradrenergic function also impair sustained attention in humans, 13 but these deficits can be reversed by the provision of phasic alerts that extrinsically release noradrenaline from the locus coeruleus. Functional imaging studies have generally confirmed this model by showing that sustained attention is achieved through the reciprocal interaction between cortical and subcortical areas. Specifically, the right dorsolateral prefrontal cortex, anterior cingulated, and inferior parietal lobe act to exert top-down (endogenous) control, via thalamic nuclei, over the locus coeruleus to promote release of noradrenaline. 8, 11, [14] [15] [16] [17] It follows that the sustained attention deficits of rightfrontal patients may stem from a failure to endogenously regulate alertness in a top-down fashion, and that activating intact phasic alertness systems may therefore ameliorate these deficits. In support of this relationship we have argued that the sustained attention deficits in TBI arise from a failure to endogenously maintain alertness, 14, 18 and have shown that phasic alerting cues can improve the ability of TBI patients to effectively maintain task goals. 19 More recently, we have also demonstrated that sustained attention deficits in children with ADHD 20 can be ameliorated by the provision of random phasic alerts designed to heighten activity within RH networks.
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Molecular Genetics of Sustained Attention
Sustained attention deficits are prominent in a number of heritable disorders with a putative dysfunction of catecholamine signaling. Familial influences on sustained attention have been reported in both schizophrenia 22, 23 and ADHD, with unaffected siblings performing better than affected siblings, but worse than healthy controls. 24 Cornblatt and colleagues have long argued that deficient sustained attention is an appropriate endophenotype for schizophrenia. 25, 26 A large body of evidence also supports the existence of sustained attention deficits in children, adolescents, and adults with ADHD.
20,27-29 Groot et al. 30 recently examined familial influences on sustained attention in preschoolers using the Amsterdam Neuropychological Tasks. Correlations of performance measures were generally higher in monozygotic than dizygotic twin pairs, suggesting a genetic influence. Heritability estimates for sustained attention measures were generally moderate (0.46-0.72), however, and model-fitting suggested the influence of both genetic and unique environmental effects (see also Refs. 31 and 32).
Candidate Genes and Sustained Attention
Several studies have examined the association between candidate genes for ADHD and sustained attention (see TABLE 2.). The dopamine transporter gene (DAT1; 5p15.3) is a likely candidate gene for ADHD because methylphenidate (MPH), the mainstay treatment for ADHD, acts by inhibiting the reuptake of dopamine (and noradrenaline) via the dopamine transporter (DAT). Meta-analyses indicate that DAT1 is a susceptibility gene for ADHD with an estimated odds ratio of around 1.2. 33 Since it has been reported that MPH improves sustained attention in children with ADHD, 34 several studies have investigated whether allelic variation in DAT1 influences sustained attention capacity in ADHD participants. Bellgrove et al. 35 and Loo et al. 36 tested for association of sustained attention capacity in children with ADHD and variation in the DAT1 gene, using a variable number of tandem repeat (VNTR) polymorphism (see TABLE 1) within the 3 UTR region of the gene. The 10-repeat allele of this variant confers risk to ADHD and may influence the stability of mRNA, and so affect expression levels of DAT. 37, 38 Several studies have reported elevated DAT densities in the striatum of children and adults with ADHD, and these are apparently normalized with MPH, but others have failed to replicate this finding. [39] [40] [41] [42] [43] There is also evidence that children and adults who are homozygous for the 10-repeat DAT1 may have higher availability of DAT protein in the striatum, relative to those with the 9-repeat/10-repeat genotype. 44, 45 In both Bellgrove et al. and Loo et al., children who were homozygous for the 10-repeat allele displayed poorer sustained attention, reflected in greater commission or omission errors relative to those carrying the 9-repeat allele. Both studies also reported an influence of DAT genotype on response-time variability, indicating that 10-repeat homozygotes were impaired in exerting consistent attentional control over the duration of the task. Given the co-occurrence of sustained attention deficits and dopaminergic dysfunction in schizophrenia, DAT1 may also be an attractive candidate gene for this disorder. To date, a comparable influence of DAT1 variants on sustained attention in nonclinical participants has not been demonstrated.
As discussed earler in this chapter, drugs that modulate noradrenergic neurotransmission have been shown to alter performance on tests of sustained attention. Bellgrove et al. 2 examined the association of dopamine beta hydroxylase (DBH) genotype with measures of sustained attention in children with ADHD (TABLE 2.). Dopamine beta hydroxylase (DβH is the enzyme that catalyzes the conversion of dopamine to noradrenaline within noradrenergic neurons. DβH activity exists within the plasma as a stable and heritable trait, and a number of polymorphisms within the DBH gene have been identified that influence DβH activity. 46 One of these polymorphisms is a Taq I variant within intron-5 of the gene, the A2 allele of which has been associated with ADHD in a number of studies. 47, 48 Since noradrenergic neurons containing DβH project strongly to the frontal cortex and could potentially modulate activity within sustained attention networks, Bellgrove et al. asked whether possession of the A2 allele would influence sustained attention in children with ADHD. In line with expectations, ADHD children who were homozygous for the A2 allele made more errors of commission than those ADHD children without this allele. This study therefore provides preliminary evidence for an association between a noradrenergic system gene and sustained attention capacity.
A number of studies have also examined sustained attention as a function of variation in dopamine receptor genes, such as DRD4 and DRD2. An association with the 7-repeat allele of a 48-bp VNTR within exon 3 of this gene is the best replicated molecular genetic finding in ADHD, 49 although the functional significance of this variant remains unclear. Studies of the cognitive correlates of the DRD4 7-repeat allele in ADHD have yielded mixed results. Several studies have reported that carriers of the 7-repeat allele perform better than those without this allele on a range of cognitive operations, including sustained attention and response-time variability. [50] [51] [52] Swanson et al. have argued that the 7-present ADHD group is characterized by extreme behavior but intact cognition, whereas the 7-absent ADHD group may carry other genetic or nongenetic abnormalities that place these children at increased risk for poorer cognitive function. 50 In line with the initial report by Swanson and colleagues, Bellgrove et al. reported that ADHD children without the 7-repeat allele performed more poorly on tests of sustained attention than ADHD children with this allele. 53 recently provided anatomical support for the relationship between cognitive function and the 7-repeat allele by showing that the DRD4 genotype influenced prefrontal brain volumes in a sample of children with ADHD, their unaffected siblings, and controls. Specifically, carriers of a variant form of the VNTR, such as the 7-repeat, had larger prefrontal volumes than individuals who were homozygous for the 4-repeat allele. These data provide further support for the argument of Swanson et al. that children without the 7-repeat allele might have compromised brain function arising from other genetic or nongenetic factors. Nevertheless, several other studies have reported that ADHD carriers of the 7-repeat allele have impaired sustained attention on versions of the continuous-performance task (CPT), 54, 55 and that possession of other variants, such as the 4-repeat allele, might have protective value. 54 Thus, the exact relationship between the DRD4 genotype and sustained attention deficits in ADHD remains unclear, with the data suggesting significant allelic heterogeneity between samples that may give rise to conflicting results.
One study has also examined the relationship between allelic variation in a Taq 1 polymorphism within the 3 UTR region of the DRD2 gene. 56 The A1 allele of this variant is reliably associated with alcoholism and appears to alter the density of D2 receptors in the striatum and nucleus accumbens. Rodríguez-Jiménez et al. found that possession of the A1 allele, relative to the A2 allele, was associated with poorer sustained attention on a version of the CPT, as well as poorer inhibitory control on a stop-signal task. 56 Interestingly, it has also been reported that possession of the A1 allele is associated with higher density of the dopamine transporter, 57 raising the possibility that gene-gene interactions between dopaminergic genes may be important for understanding the molecular genetics of processes such as sustained attention.
In summary, a number of studies have identified allelic variants of catecholamine genes (DAT1, DBH, DRD4, DRD2) that are associated with sustained attention deficits primarily in clinical populations, such as ADHD. Advances in our understanding of the molecular genetics of sustained attention will be achieved by examining the influence of these variants on the brain's response to sustained attention challenge in populations of nonclinical individuals.
A Cognitive-Neuroanatomical Model of Spatial Attention
In everyday life, our perceptual systems are bombarded with sensory input. We rely upon attention to select and prioritize only those inputs that are relevant to current behavioral goals. In cognitive neuroscience, spatial attention is often measured using attentionalorienting paradigms in which a target stimulus is preceded in time by a spatial cue. In different cuing conditions, the cue predicts the target location correctly (validly cued trials), incorrectly (invalidly cued trials), or uninformatively (neutrally cued trials). 58 Such orienting tasks typically yield reaction-time (RT) effects that reflect the operation of spatial selective attention. First, when attention is cued validly to a target location, RTs are typically faster than when the target is preceded by a neutral cue. This RT benefit reflects the attentional enhancement of perceptual processing at validly cued locations. In contrast, the disadvantage or "cost" in RT conferred by invalid cues, relative to neutral cues, reflects the time taken to reorient attention from the invalidly cued location to detect a target in an uncued location. 59 A distinction may also be made between strategic, or endogenous, and stimulus-driven, or exogenous, orienting of spatial attention. The former operates when attention is directed based on a cue that predicts target location, for example. The latter may operate when attention is captured, more or less automatically, by a sudden-onset peripheral stimulus.
Advances in our understanding of the neural bases of human spatial attention have been aided by the study of neurological patients with orienting impairments, such as unilateral spatial neglect, and by modern functional neuroimaging. The syndrome of neglect is characterized by a pathological bias of spatial attention toward the ipsilesional side, so that patients fail to act upon or detect stimuli that are presented in contralesional space. Although neglect is a common consequence of damage to the inferior parietal lobe [particularly the temporoparietal junction (TPJ)], it can also arise from a lesion to the inferior frontal cortex or superior temporal gyrus, as well as sub-cortical areas such as the basal ganglia and thalamus. 60 The syndrome of unilateral spatial neglect is often used as evidence for the dominance of the right hemisphere for spatial attention. Thus, lesions within the righthemisphere system give rise to a bias of attention that is more severe and persistent than in cases of comparable damage to the left hemisphere. This scenario may arise because the right hemisphere controls attention to both left and right space, whereas the left hemisphere may do so only for right space. 61 Accordingly, stimuli presented in the left field are more vulnerable to disruption. Using spatial-orienting tasks of the type described earlier, it has been shown that patients with damage to the right parietal lobe have difficulty reorienting their attention from an invalid cue in the right hemifield to detect a target presented in contralateral space. 62 Thus an ipsilesional bias of attention and a reorienting deficit for contralesional stimuli are hallmarks of the neglect syndrome, and evidence for the dominance of right-hemisphere networks for spatial attention.
Modern neuroimaging has largely confirmed the insights gained from neuropsychological studies in neglect patients. Broadly speaking, tasks in which attention is strategically allocated to a spatial location, in response to, for example, a centrally presented predictive arrow, activate a bilateral network of brain regions that has been conceptualized as forming a dorsal frontoparietal network. 6 This network is thought to comprise the frontal eye fields and the dorsal posterior parietal cortex along the intraparietal sulcus. This bilateral, dorsal frontoparietal network may be contrasted to a right-lateralized, ventral frontoparietal network that includes the inferior frontal gyrus (IFG) and TPJ. 6 The latter network is activated when sensory stimuli, such as a sudden-onset cue, reorient attention toward an unexpected event of behavioral significance. In most everyday circumstances, however, efficient attentional allocation requires the interaction of both top-down (strategic) and bottom-up (automatic) processes.
The neurochemical substrates of spatial attention have been investigated by utilizing visual orienting paradigms within pharmacological challenge studies. In humans and nonhuman primates, cholinergic agonists increase the speed of attentional orienting and reduce the costs associated with invalid cues within exogenous cuing paradigms. 63 In contrast, damage to brain-stem cholinergic projections impairs attentional orienting to visual targets in nonhuman primates 64 and in patients with Alzheimer's disease. 65 A number of studies have also suggested that noradrenergic mechanisms may be important for maintaining alertness during visual orienting paradigms, 66, 67 but are less critical for spatial orienting. Thus the α2 noradrenergic agonist clonidine has been shown to reduce the benefit of alerting cues, relative to a no-cue condition, within visual orienting paradigms. 66 Two studies have, however reported that clonidine attenuated the cost of invalid spatial cues. 67, 68 In a study by Coull et al., clonidine acted to facilitate the reorienting of attention from invalid cues in the right field. This effect was asymmetrical, in that it did not occur for invalid left cues (right visual field targets). Speeded re-orienting was associated with a reduction in activity in the right superior parietal cortex. 67 Thus, there is good evidence for noradrenergic modulation of the benefit conferred by a temporal warning cue, and for a contribution by cholinergic and noradrenergic mechanisms in the processing of spatial cues.
Current models of visual attention propose a role for dopamine in the executive control of attention, with little contribution toward mechanisms of spatial attention. 7 Yet there are good reasons to suspect that dopamine may play a role in directing spatial attention. First, although there is minimal dopaminergic input into the parietal lobe in rodents, there is a substantial input in primates. 69 In fact, dopamine projections to the parietal cortex in primates are similar in their extent to those to the frontal cortex. Asymmetries of spatial attention have also been observed in a number of clinical conditions with a putative dopaminergic origin, including schizophrenia and ADHD; these deficits are ameliorated by antipsychotics and stimulants, respectively. [70] [71] [72] In patients with the neglect syndrome, treatment with dopamine agonists has also been shown to reduce the extent of unilateral neglect. 73 As will be discussed shortly, there is also evidence that variation within the dopamine transporter gene (DAT1) is associated with spatial attention in both healthy children and those with ADHD.
Molecular Genetics of Spatial Attention
Candidate Genes and Spatial Attention
As can be seen from TABLE 2, several studies have examined the molecular genetic correlates of spatial attention in both healthy and clinical populations. Arguably the best replicated association is between the ε4 allele of the apolipoprotein E (ApoE) gene and spatial attention. [74] [75] [76] The ε4 allele of the ApoE gene on chromosome 19 has been identified as a major risk factor for the development of late-onset Alzheimer's disease. 77 Patients with Alzheimer's disease have been shown to have robust deficits on visual orienting tasks, manifesting as a deficit in reorienting attention from invalidly cued locations. 78 This behavioral deficit accords well with structural imaging findings showing deficits in the parietal cortex in patients with Alzheimer's disease. 79 A number of studies have now shown that the ε4 allele of the ApoE gene influences spatial attention in an allele dosage manner in healthy middleaged and older adults. Specifically, possession of more copies of the ε4 allele (0, 1, or 2) has been shown to slow reaction time to invalidly cued trials. 74, 75 It is still not clear exactly how variation in the ApoE gene might influence spatial attention. Parasuraman and colleagues have suggested that ApoE might modulate the influence of cholinergic inputs to the parietal lobe and so influence spatial attention. 80 More recently, Espeseth et al. 75 have reported an interaction between ApoE genotype and allelic variation in a cholinergic receptor gene,CHRNA4, suggesting that ApoE might modulate the cholinergic system to influence spatial attention. This finding is discussed further later in this chapter.
As reviewed earlier, converging evidence from cognitive neuroscience and psychopharmacology suggest that cholinergic mechanisms may modulate spatial attention in humans. Basing their conclusions on evidence for cholinergic innervation in the parietal cortex, Parasuraman et al. 81 hypothesised that polymorphisms of nicotinic acetylcholine receptors (nAChRs) might modulate spatial attention. In a sample of 89 healthy adults, Parasuraman et al. tested for association between a C1545T polymorphism of the gene controlling the alpha-4 subunit of a nicotinic receptor gene (CHRNA4) and individual differences in endogenous spatial attention. CHRNA4 genotype was associated with increased benefits of valid spatial cues and reduced costs of invalid cues. Specifically, homozygotes for the C allele showed increased benefits and reduced costs, whereas T allele homozygotes showed the reverse pattern. Although the functional significance of this polymorphism remains unclear, this study provided preliminary evidence that a cholinergic receptor polymorphism influences individual differences in spatial attention. Further evidence for the influence of this polymorphism on spatial attention was provided in a follow-up study that examined individual differences in the ability to scale the focus of spatial attention. 82 In this case, however, C allele homozygotes had a poorer ability to scale the focus of attention, relative to the T allele carriers; 82 this finding is at odds with the results of the previous study showing that C allele homozygotes have more efficient spatial orienting.
Interactive effects of APOE and CHRNA4 polymorphisms on spatial attention have also been reported. 75 In a sample of 230 middle-aged and older adults, APOE and CHRNA4 were found to interact to influence the speed of attentional reorienting. Specifically, the cost to reaction time associated with invalid cues was greater in APOE-ε4 carriers who were also homozygous for the T allele of the CHRNA4 marker. 75 APOE and CHRNA4 genotype also interacted to influence white-matter volumes, with the APOE-ε4/TT CHRNA4 group showing the greatest reduction in volume. 75 Taken together, the findings just reviewed are consistent with a view that individual differences in spatial attention can be accounted for in part by allelic variation in genes influencing cholinergic neurotransmission. Future work will need to determine how the APOE-ε4 or CHRNA4 C/T alleles alter gene function and the physiological substrates of spatial attention.
A number of studies have also tested for association between dopaminergic candidate genes and spatial attention in children with ADHD and nonclinical control children. ADHD has been reported to be associated with anomalies of spatial attention, such that children are slower to respond to targets in the left visual field, are slower to re-orient attention their attention to the left visual field, and have a bias of attention in favor of the right visual field. 71, 72, 83 This behavioral profile is qualitatively similar to that seen in the parietal-neglect syndrome, and is consistent with the predominantly right-hemisphere pathology of ADHD. Importantly, spatial attentional asymmetries in ADHD can be ameliorated by stimulants, such as methylphenidate, which act to inhibit the DAT. 71 As reviewed earlier, the dopamine transporter gene (DAT1) is an established susceptibility gene for ADHD. Bellgrove et al. built on these lines of evidence to ask whether spatial attentional asymmetries in ADHD might relate to allelic variation in polymorphisms of the DAT1 gene. 35, 84 Across two studies employing clinical tests of neglect, such as line bisection, Bellgrove et al. reported that children with ADHD who were homozygous for the 10-repeat allele of the DAT1 polymorphism showed a bias of attention away from the left visual field. 35, 84 This bias of attention is again analogous to the ipsilesional bias seen in the neglect syndrome. Given the strong involvement of the posterior parietal cortex during line bisection, 85 these results imply a dopaminergic modulation of parietal cortex during spatial processing. This relationship gains additional support from observations of high densities of DAT immunoreactive axons within the posterior parietal cortex. 86 Support for the association of DAT1 variants and spatial attention also comes from a study of 51 healthy nonclinical children who performed an exogenous orienting task. 59 In this study attention was directed to one or the other visual field by sudden-onset, brief peripheral cues that were valid, neutral, or invalid. Participants were genotyped for both the 3 UTR VNTR and an additional VNTR within intron-8 that has more recently been associated with ADHD. Together, the 10-and 3-repeat alleles of these markers form a common DAT1 haplotype (10/3) that appears to confer risk to ADHD with an odds ratio of around 2.6. This haplotype may also be associated with increased expression levels of DAT. 38 Haplotypes represent sets of closely linked DNA and can be used to accurately identify a region of a gene that may harbor a causative variant for a disease, or in this case a trait. In line with previous work in children with ADHD, this study found that healthy nonclinical children who were homozygous for the 10-or 3-repeat alleles of the 3 UTR and intron-8 VNTRs were slower to respond to targets in the left hemifield when their attention had been invalidly cued to the right hemifield ( see FIG. 1A and  1B) . 59 This behavioral profile was asymmetric in that it did not occur for right hemifield targets preceded by leftsided cues. Homozygosity for the 10/3 DAT1 haplotype was also associated with slower responses to left hemifield targets when these were preceded by invalid spatial cues in the right hemifield (FIG. 1C) . Bellgrove et al. argued that these data suggest that a FIGURE 1. Cuing cost (invalid RT-neutral RT) as a function of target side and DAT1 genotype in a group of nonclinical children performing a spatial orienting task. (A) Cuing costs plotted with respect to DAT1 genotype at the 3 UTR VNTR. 10-repeat homozygotes (10/10 3 UTR DAT1) are compared to 10-repeat heterozygotes (10/9 3 UTR DAT1). The 10/10 group display greater overall cuing costs than the 10/9 group (P < .05). The 10/10, relative to 10/9, group showed greater cuing costs for targets in the left hemifield (P < .01). (B) Cuing costs plotted with respect to DAT1 genotype at the intron-8 VNTR. The 3-repeat homozygotes (3/3 intron-8 DAT1) exhibited greater cuing costs for targets in the left hemifield compared to 3-repeat heterozygotes (3/2 intron-8 DAT1) (P < .02). Cuing costs were asymmetrical for the 3/3 group, being higher for targets in the left, compared to right, hemifield (P < .02). (C) Cuing costs as a function of DAT1 haplotype (10/3) group. Participants who were homozygous for the 10/3 DAT1 haplotype (2-10/3 DAT1 haplotypes) exhibited greater cuing costs for targets in the left, relative to right, hemifield (P = .06). No asymmetry was evident for participants who were heterozygous for the 10/3 DAT1 haplotype (1-10/3 DAT1 haplotype). (Reproduced by permission from Bellgrove et al. 59 )
QTL for spatial attentional bias may lie in the region defined by intron-8 and the 3 UTR markers of the DAT1 gene. A testable hypothesis arising from this work is that the right-hemisphere spatial attention network, which includes the parietal lobe, may be differentially modulated as a function of DAT1 variants. In the context of ADHD, these data further suggest that some of the genetic risk conferred by DAT1 variants may operate in part through their effects on the neural networks for spatial attention. Whether spatial attention (bias) may have utility as an endophenotype for ADHD will, however, need to be confirmed in future studies.
Molecular Genetics of Attention and Genomewide Association Studies
Sustained and spatial attention, like most cognitive processes, are undoubtedly polygenic traits. The literature reviewed here has identified a range of novel associations between genetic variants and behavioral measures of sustained or spatial attention, in both clinical and nonclinical populations. As we argued earlier in this chapter, for the most part the search for these "candidate genes" has been guided by cognitiveneuroanatomical models of sustained and spatial attention. Although the candidate-gene approach to attention has identified a number of associations that are worthy of replication, there are likely a range of as-yet-unknown genes that may have a minor or major influence on attention. Recent advances in the development of high-throughput genotyping techniques, such as microarrays, now allow us to search for genetic associations using 500 K or even 1 million markers (e.g., SNPs) distributed across the genome (see Ref. 87 ). So-called genomewide association studies have the potential to identify novel associations with genes for which no a priori evidence is available. Although genomewide association studies are often used to compare allele frequencies between cases and controls across the genome, they can also be used to compare allele frequencies between individuals who score high or low on a quantitative measure, such as a test of attention. Although no genomewide association studies of sustained or spatial attention have been conducted, lessons can be learned from comparable studies of memory.
Papassotiropoulos et al. conducted a genomewide association study of episodic memory using 500 SNPs in a sample of 341 young adults. 88 By stratifying the sample into four groups according to their performance on a task of episodic memory (verbal delayed recall), these authors could examine differences in allele frequencies across the genome as a function of episodic memory capacity. After applying stringent safeguards for Type-1 error, two SNPs were identified. The first SNP was a common T-C substitution within intron-9 of a gene, KIBRA, encoding a neuronal protein.
The second SNP was a common T-C substitution within intron-1 of CLSTN2, encoding synaptic protein calsyntenin-2. Association between KIBRA and memory performance was subsequently confirmed in two additional and independent samples of cognitively normal participants, whereas no influence of this SNP was found on tasks of attention, concentration, and working memory. Expression levels of KI-BRA in memory-related brain regions were assessed and revealed high expression in the hippocampus and temporal lobe; in situ hybridization studies in mice further revealed maximal KIBRA expression in the dentate gyrus and CA1 region of the hippocampal formation. Furthermore, 15 carriers of the T-allele of the associated SNP were compared to 15 noncarriers using fMRI and an associative episodic memory task. Noncarriers of the T allele showed increased brain activation during retrieval in the medial temporal lobe compared with T-allele carriers, consistent with the hypothesis that this group would require greater activation to attain comparable performance levels to the T-allele carriers. In summary, this elegant study identified a novel memory gene, KIBRA, using the method of genomewide association within healthy populations. Subsequent analyses confirmed that allelic variation at this locus influenced the efficiency of the neural networks for episodic memory. This study therefore identified a novel memory gene that may now be tested for association in a range of heritable memory disorders.
Genes for sustained and spatial attention could be identified in the future using an analogous approach to that employed by Papassotiropoulos et al. 88 for episodic memory. Once identified, it should then be possible to link variation in these "attention genes" to the neural substrates of attention, including the frontoparietal cortices. In addition to the inherent value of a genomewide association study of attention to those interested in cognitive neuroscience, such a study will hopefully provide novel candidates for genetic association studies of disorders of attention, such as ADHD and schizophrenia.
